DGNS Relative Valuation - Diagnos Laboratorium Utama PT Tbk

Watchlist Manager

Watchlist

Price: 300 IDR 2.74% Market Closed

Market Cap: Rp375B

D	Diagnos Laboratorium Utama PT Tbk IDX:DGNS	ID
D	DV 8 PCL SET:DV8	TH

Multiples-Based Value

The Multiples-Based Value of one DGNS stock under the Base Case scenario is 422.68 IDR. Compared to the current market price of 300 IDR, Diagnos Laboratorium Utama PT Tbk is Undervalued by 29%.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Multiples-Based Value calculated?

DGNS Multiples-Based Value

Base Case

Undervaluation 29%

Multiples-Based Value

Price

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
ID	D	Diagnos Laboratorium Utama PT Tbk IDX:DGNS	375B IDR	1.3	-197.1	-6 277.3	-6 277.3
US		CVS Health Corp NYSE:CVS	89.1B USD	0.2	50.4	13.3	13.3
US	C	Cigna Group XMUN:CGN	68B EUR	0.3	13.4	7.8	9.9
US		Cigna Corp NYSE:CI	69B USD	0.3	11.6	0	0
DE		Fresenius SE & Co KGaA XETRA:FRE	24.8B EUR	1.1	19.5	9.3	13.8
DE		Fresenius Medical Care AG XMUN:FME	22.5B EUR	1.2	23.3	9	16.6
US		Laboratory Corporation of America Holdings NYSE:LH	21.7B USD	1.6	24.8	11.9	17.3
US		Quest Diagnostics Inc NYSE:DGX	21.5B USD	1.9	21.8	11.8	15.9
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	10.9B EUR	0.5	11	5.3	9.8
US		Guardant Health Inc NASDAQ:GH	11.1B USD	11.3	-26.6	-29.1	-26.4
US		DaVita Inc NYSE:DVA	10.6B USD	0.8	14.2	7.3	9.8

				Revenue Growth	P/S to Growth
ID	D	Diagnos Laboratorium Utama PT Tbk IDX:DGNS	Average P/S: 1.9 1.3	N/A	N/A
US		CVS Health Corp NYSE:CVS	0.2	4%	0.1
US	C	Cigna Group XMUN:CGN	0.3	6%	0
US		Cigna Corp NYSE:CI	0.3	6%	0
DE		Fresenius SE & Co KGaA XETRA:FRE	1.1	5%	0.2
DE		Fresenius Medical Care AG XMUN:FME	1.2	3%	0.4
US		Laboratory Corporation of America Holdings NYSE:LH	1.6	6%	0.3
US		Quest Diagnostics Inc NYSE:DGX	1.9	5%	0.4
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	0.5	3%	0.2
US		Guardant Health Inc NASDAQ:GH	11.3	29%	0.4
US		DaVita Inc NYSE:DVA	0.8	4%	0.2

				Earnings Growth	PEG
ID	D	Diagnos Laboratorium Utama PT Tbk IDX:DGNS	Average P/E: 21.1 Negative Multiple: -197.1	N/A	N/A
US		CVS Health Corp NYSE:CVS	50.4	90%	0.6
US	C	Cigna Group XMUN:CGN	13.4	19%	0.7
US		Cigna Corp NYSE:CI	11.6	19%	0.6
DE		Fresenius SE & Co KGaA XETRA:FRE	19.5	26%	0.7
DE		Fresenius Medical Care AG XMUN:FME	23.3	16%	1.5
US		Laboratory Corporation of America Holdings NYSE:LH	24.8	27%	0.9
US		Quest Diagnostics Inc NYSE:DGX	21.8	12%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	11	16%	0.7
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -26.6	N/A	N/A
US		DaVita Inc NYSE:DVA	14.2	20%	0.7

				EBITDA Growth	EV/EBITDA to Growth
ID	D	Diagnos Laboratorium Utama PT Tbk IDX:DGNS	Average EV/EBITDA: 9.5 Negative Multiple: -6 277.3	N/A	N/A
US		CVS Health Corp NYSE:CVS	13.3	28%	0.5
US	C	Cigna Group XMUN:CGN	7.8	4%	2
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	9.3	10%	0.9
DE		Fresenius Medical Care AG XMUN:FME	9	7%	1.3
US		Laboratory Corporation of America Holdings NYSE:LH	11.9	10%	1.2
US		Quest Diagnostics Inc NYSE:DGX	11.8	6%	2
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	5.3	7%	0.8
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -29.1	N/A	N/A
US		DaVita Inc NYSE:DVA	7.3	4%	1.8

				EBIT Growth	EV/EBIT to Growth
ID	D	Diagnos Laboratorium Utama PT Tbk IDX:DGNS	Average EV/EBIT: 13.3 Negative Multiple: -6 277.3	N/A	N/A
US		CVS Health Corp NYSE:CVS	13.3	22%	0.6
US	C	Cigna Group XMUN:CGN	9.9	5%	2
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	13.8	12%	1.2
DE		Fresenius Medical Care AG XMUN:FME	16.6	11%	1.5
US		Laboratory Corporation of America Holdings NYSE:LH	17.3	18%	1
US		Quest Diagnostics Inc NYSE:DGX	15.9	9%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	9.8	11%	0.9
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -26.4	N/A	N/A
US		DaVita Inc NYSE:DVA	9.8	5%	2

Diagnos Laboratorium Utama PT Tbk
IDX:DGNS

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

DGNS Competitors Multiples
Diagnos Laboratorium Utama PT Tbk Competitors

See Also

Company

Help

Tools

Stocks

Diagnos Laboratorium Utama PT Tbk IDX:DGNS

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

DGNS Competitors Multiples Diagnos Laboratorium Utama PT Tbk Competitors

See Also

Company

Help

Tools

Stocks

Diagnos Laboratorium Utama PT Tbk
IDX:DGNS

DGNS Competitors Multiples
Diagnos Laboratorium Utama PT Tbk Competitors